ARCHIVES

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

NCI Will Encourage More Nutrition Research, Upton Tells McGovern

June 23, 1978

Four Center Grants In Danger; Shingleton to Retire, Owen Promoted At Hopkins

January 9, 1987

Project Expands Group Studies To Community Oncologists.

March 10, 2000

AACR Elion Award Deadline Is Jan. 10

September 16, 1994